The Asia-Pacific med tech market is being propelled by constantly aging demographics, a rise in chronic diseases, and a growing population. Since the pandemic, it has been experiencing trends such as 3D printing for customized equipment, incorporating robotics in healthcare, and augmented reality (AR).
The market has attracted international attention, with global players seeking to invest. As a result, the market value of the med tech industry in the Asia-Pacific region is projected to reach a staggering US$135.80bn in 2022. This value is anticipated to expand at a 6.27 percent compound annual growth rate (CAGR) to US$184.10bn by 2027.
This issue of Med Tech Outlook APAC features the ‘Top 5 Med Tech Companies in China - 2022’, which highlights some of the key developments in the medical technology space and how the industry has experienced significant growth in recent years, despite pandemic-driven market limitations.
It features companies like Singular Medical, a tech business that focuses on developing and manufacturing cardiac rhythm management products. In addition to cardiac pacemakers and defibrillators, Singular Medical develops an ecosystem of solutions for heart disease screening, wearable cardiopulmonary monitoring, and heart rhythm monitoring.
The edition also includes companies like Intelligent Surgery Equipment, which highlights the advancements in robotics in the surgical equipment sector in China.
The magazine also includes the insightful viewpoints of Adjunct Assistant Professor Kelvin Tan, Head of Service (Adult Reconstruction), Consultant Orthopedic Surgery, Tan Tock Seng Hospital, and D. Karl Marlowe, Consultant Psychiatrist and Chief Medical Officer, Oxford Health NHS Foundation Trust. They each discuss how the field of orthopedic care has changed over time and how medical technology can be used to give services or manage mental health.
Write to us about how the advancements in medical technology in Asia- Pacific countries have affected the functioning of your organizations!
